Importer of Controlled Substances Application: VHG Labs dba LGC Standards, 67361-67362 [2023-21398]
Download as PDF
<![CDATA[
Federal Register / Vol. 88, No. 188 / Friday, September 29, 2023 / Notices
The company plans to import the
listed controlled substances for sale to
research facilities for drug testing and
analysis. In reference to drug codes 7360
(Marihuana) and 7370
(Tetrahydrocannabinols) the company
plans to import a synthetic cannabidiol
and a synthetic tetrahydrocannabinol.
No other activities for these drug codes
are authorized for this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Claude Redd,
Acting Deputy Assistant Administrator.
[FR Doc. 2023–21399 Filed 9–28–23; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
In
accordance with 21 CFR 1301.34(a), this
is notice that on August 3, 2023, Curia
Wisconsin, Inc., 870 Badger Circle,
Grafton, Wisconsin 53024–9436,
applied to be registered as an importer
of the following basic class(es) of
controlled substance(s):
SUPPLEMENTARY INFORMATION:
Controlled substance
[Docket No. DEA–1276]
Gamma Hydroxybutyric
Acid.
Marihuana Extract ........
Marihuana .....................
Dimethyltryptamine .......
Importer of Controlled Substances
Application: Curia Wisconsin, Inc.
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Curia Wisconsin, Inc. has
applied to be registered as an importer
of basic class(es) of controlled
substance(s). Refer to SUPPLEMENTARY
INFORMATION listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before October 30, 2023. Such
persons may also file a written request
for a hearing on the application on or
before October 30, 2023.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
21:46 Sep 28, 2023
Jkt 259001
Drug
code
Schedule
2010
I
7350
7360
7435
I
I
I
The company plans to import
Dimethyltryptamine and a derivative of
Gamma Hydroxybutyric Acid to support
post procurement reprocessing. The
cannabidiol from Marihuana and
Marihuana Extract is intended for
analytical purposes with
Tetramethylpyrazine (TMP). No other
activities for these drug codes are
authorized for this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Claude Redd,
Acting Deputy Assistant Administrator.
[FR Doc. 2023–21403 Filed 9–28–23; 8:45 am]
BILLING CODE P
PO 00000
Frm 00137
Fmt 4703
Sfmt 4703
67361
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1261]
Importer of Controlled Substances
Application: VHG Labs dba LGC
Standards
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
VHG Labs dba LGC Standards
has applied to be registered as an
importer of basic class(es) of controlled
substance(s). Refer to SUPPLEMENTARY
INFORMATION listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before October 30, 2023. Such
persons may also file a written request
for a hearing on the application on or
before October 30, 2023.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on August 16, 2023, VHG
Labs dba LGC Standards, 3 Perimeter
Road, Manchester, New Hampshire
03103–3341, applied to be registered as
an importer of the following basic
class(es) of controlled substance(s):
SUMMARY:
E:\FR\FM\29SEN1.SGM
29SEN1
67362
Federal Register / Vol. 88, No. 188 / Friday, September 29, 2023 / Notices
Controlled substance
Drug code
Para-Methoxymethamphetamine (PMMA), 1-(4- methoxyphenyl)-N-methylpropan-2-amine .................................
Aminorex .................................................................................................................................................................
Etizolam (4-(2-chlorophenyl)-2-ethyl-9-methyl-6Hthieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine .........................
Flualprazolam (8-chloro-6-(2-fluorophenyl)-1-methyl-4Hbenzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine) ....................
Clonazolam (6-(2-chlorophenyl)-1-methyl-8-nitro-4Hbenzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine ...........................
Flubromazolam (8-bromo-6-(2-fluorophenyl)-1-methyl4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine ...................
Diclazepam (7-chloro-5-(2-chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one ........
Piritramide ...............................................................................................................................................................
Lisdexamfetamine ...................................................................................................................................................
Oliceridine (N-[(3-methoxythiophen-2yl)methyl] ({2-[9r)-9-(pyridin-2-yl)-6-oxaspiro[4.5] decan-9-yl] ethyl
{time})amine fumarate).
Levo-alphacetylmethadol .........................................................................................................................................
Remifentanil .............................................................................................................................................................
Tapentadol ...............................................................................................................................................................
The company plans to import the
listed controlled substances for
distribution for analytical testing
purposes. No other activities for these
drug codes are authorized for this
registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Claude Redd,
Acting Deputy Assistant Administrator.
[FR Doc. 2023–21398 Filed 9–28–23; 8:45 am]
BILLING CODE P
Drug Enforcement Administration
[Docket No. DEA–1272]
Bulk Manufacturer of Controlled
Substances Application: Restek
Corporation
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Restek Corporation has
applied to be registered as a bulk
manufacturer of basic class(es) of
controlled substance(s). Refer to
SUPPLEMENTARY INFORMATION listed
below for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before November 28, 2023. Such
persons may also file a written request
for a hearing on the application on or
before November 28, 2023.
lotter on DSK11XQN23PROD with NOTICES1
Jkt 259001
PO 00000
Frm 00138
Fmt 4703
9648
9739
9780
II
II
II
Drug code
Gamma Hydroxybutyric Acid ...................................................................................................................................
Methaqualone ..........................................................................................................................................................
JWH–018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) ......................................................................
JWH–200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) ..................................................................................
CP–47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) ........................................................
CP–47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) ..................................
Lysergic acid diethylamide ......................................................................................................................................
Marihuana ................................................................................................................................................................
Tetrahydrocannabinols ............................................................................................................................................
4-Methyl-2,5-dimethoxyamphetamine .....................................................................................................................
3,4-Methylenedioxyamphetamine ............................................................................................................................
3,4-Methylenedioxy-N-ethylamphetamine ...............................................................................................................
3,4-Methylenedioxymethamphetamine ....................................................................................................................
Bufotenine ...............................................................................................................................................................
Psilocybin ................................................................................................................................................................
Psilocyn ...................................................................................................................................................................
Cyprenorphine .........................................................................................................................................................
Dihydromorphine .....................................................................................................................................................
Heroin ......................................................................................................................................................................
Normorphine ............................................................................................................................................................
Beta-hydroxyfentanyl ...............................................................................................................................................
Beta-hydroxy-3-methylfentanyl ................................................................................................................................
21:46 Sep 28, 2023
I
I
I
I
I
I
I
I
II
II
The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.33(a), this
is notice that on June 21, 2023, Restek
Corporation, 110 Benner Circle,
Bellefonte, Pennsylvania 16823–8433,
applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substance(s):
Controlled substance
VerDate Sep<11>2014
1245
1585
2780
2785
2786
2788
2789
9642
1205
9245
ADDRESSES:
DEPARTMENT OF JUSTICE
SUMMARY:
Schedule
Sfmt 4703
E:\FR\FM\29SEN1.SGM
29SEN1
2010
2565
7118
7200
7297
7298
7315
7360
7370
7395
7400
7404
7405
7433
7437
7438
9054
9145
9200
9313
9830
9831
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
]]>Agencies
[Federal Register Volume 88, Number 188 (Friday, September 29, 2023)]
[Notices]
[Pages 67361-67362]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-21398]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1261]
Importer of Controlled Substances Application: VHG Labs dba LGC
Standards
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: VHG Labs dba LGC Standards has applied to be registered as an
importer of basic class(es) of controlled substance(s). Refer to
SUPPLEMENTARY INFORMATION listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
October 30, 2023. Such persons may also file a written request for a
hearing on the application on or before October 30, 2023.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment. All
requests for a hearing must be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152. All requests for a hearing should also be
sent to: Drug Enforcement Administration, Attn: Administrator, 8701
Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on August 16, 2023, VHG Labs dba LGC Standards, 3
Perimeter Road, Manchester, New Hampshire 03103-3341, applied to be
registered as an importer of the following basic class(es) of
controlled substance(s):
[[Page 67362]]
----------------------------------------------------------------------------------------------------------------
Controlled substance Drug code Schedule
----------------------------------------------------------------------------------------------------------------
Para-Methoxymethamphetamine (PMMA), 1-(4- methoxyphenyl)-N- 1245 I
methylpropan-2-amine.
Aminorex.................................................. 1585 I
Etizolam (4-(2-chlorophenyl)-2-ethyl-9-methyl-6Hthieno[3,2- 2780 I
f][1,2,4]triazolo[4,3-a][1,4]diazepine.
Flualprazolam (8-chloro-6-(2-fluorophenyl)-1-methyl- 2785 I
4Hbenzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine).
Clonazolam (6-(2-chlorophenyl)-1-methyl-8-nitro- 2786 I
4Hbenzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine.
Flubromazolam (8-bromo-6-(2-fluorophenyl)-1-methyl4H- 2788 I
benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine.
Diclazepam (7-chloro-5-(2-chloro-5-(2-chlorophenyl)-1- 2789 I
methyl-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one.
Piritramide............................................... 9642 I
Lisdexamfetamine.......................................... 1205 II
Oliceridine (N-[(3-methoxythiophen-2yl)methyl] ({2-[9r)-9- 9245 II
(pyridin-2-yl)-6-oxaspiro[4.5] decan-9-yl] ethyl
{time{time} )amine fumarate).
Levo-alphacetylmethadol................................... 9648 II
Remifentanil.............................................. 9739 II
Tapentadol................................................ 9780 II
----------------------------------------------------------------------------------------------------------------
The company plans to import the listed controlled substances for
distribution for analytical testing purposes. No other activities for
these drug codes are authorized for this registration.
Approval of permit applications will occur only when the
registrant's business activity is consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import
of Food and Drug Administration-approved or non-approved finished
dosage forms for commercial sale.
Claude Redd,
Acting Deputy Assistant Administrator.
[FR Doc. 2023-21398 Filed 9-28-23; 8:45 am]
BILLING CODE P
